New Study Finds RIVA ‘Leading the Pack’ in Automated IV Compounding Systems

Posted on November 28, 2012

Cory Stewart
Cookerly Public Relations
(404) 816-2037

New Study Finds RIVA ‘Leading the Pack’ in
Automated IV Compounding Systems

Independent healthcare research firm KLAS reports RIVA is highest-rated system in
every category studied

(WINNIPEG, Manitoba – Nov. 28, 2012) – RIVA, the fully automated IV compounding system
manufactured by Intelligent Hospital Systems (IH Systems), is ahead of competitors in overall
performance, meeting business case expectations and customer satisfaction, according to a
new study of IV automation systems by independent healthcare research firm KLAS.

The study, “U.S. IV Automation: Robots and Workflow Solutions in 2012,” examined five
pharmacy automation systems, including RIVA and its leading competitors. The report found
that RIVA’s initial data scores were highest among all the systems studied. RIVA technology
also received high marks for having needed functionality, being ready for widespread industry
use and customers that would buy it again. Significantly, RIVA was the only IV automation
system in the study to have all customers report it was meeting or exceeding anticipated ROI.
“Safety reduces costs, and RIVA provides hospitals with a very high ‘safety dividend’ that is a
unique and invaluable aspect of its ROI,” said Dr. Niels Erik Hansen, president and CEO of
Intelligent Hospital Systems. “RIVA’s technology has been engineered to prevent human error,
which is the most common source of medication contamination and can have tragic results as
evidenced by the recent meningitis outbreak.”

From a purely financial perspective, RIVA’s ability to help hospitals and pharmacies reduce
costs also has been well documented. The technology allows users to lower the cost-per-dose
of medication, reduce the need for outsourcing and decrease waste. The system’s strong
business case was confirmed by RIVA users that participated in the KLAS study: the report
found that all RIVA customers said they were realizing their ROI, and “several indicated they
were doing better than they had expected.”

The KLAS study also highlighted a national trend toward automation which suggests RIVA is
well-positioned for substantial growth. The report found more than 90 percent of organizations
with more than 500 beds anticipate purchasing a robotic system (one component of RIVA is a
robotic arm), most within the next five years. Importantly, among the systems providers are
considering, KLAS found that “RIVA leads in mindshare.”

“RIVA sets a new standard in patient safety that hospitals and pharmacies around the world
recognize as the future of medication preparation,” Dr. Hansen added. “The KLAS study
provides further validation that RIVA is leading the way to enhanced safety, reduced costs and
increased efficiency.”

Earlier this year, IH Systems reached a significant milestone when RIVA systems globally had
collectively prepared more than 1 million doses of medication safely and accurately since its
introduction in 2008. The system’s safety record has been demonstrated by more than 50,000
routine quality control checks at 27 RIVA installations that have found no contamination in
compounds produced by the machines. The milestone was especially notable in light of the
deadly meningitis outbreak linked to pharmacy mixture contamination, which RIVA technology is
designed to prevent.

KLAS report citation: “U.S. IV Automation: Robots and Workflow Solutions in 2012,” October,
2012. © 2012 KLAS Enterprises, LLC. All rights reserved.


About Intelligent Hospital Systems

Founded in 2006, Intelligent Hospital Systems (IH Systems) is a medical device company focused on the
design and development of automated solutions for the hospital environment. Based in Winnipeg,
Manitoba, IH Systems manufactures RIVA, a fully automated IV compounding system that prepares
medications for syringes and IV bags in an aseptic environment. Using RIVA, hospitals enhance patient
safety, lower the cost-per-dose of medications, reduce their vulnerability to medication shortages and cut
waste. For more information, visit

NEWS | Press Release 2012